- Home
- LEGN
as 07-26-2024 4:00pm EST
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.9B | IPO Year: | 2020 |
| Target Price: | $80.54 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.60 - $77.30 | Next Earning Date: | 08-09-2024 |
| Revenue: | $342,798,000 | Revenue Growth: | 231.84% |
| Revenue Growth (this year): | 87.6% | Revenue Growth (next year): | 98.90% |
Latest Legend Biotech Corporation News
LEGN Breaking Stock News: Dive into LEGN Ticker-Specific Updates for Smart Investing
MT Newswires
10 hours ago
Legend Biotech Reports Preliminary First-Half Financial Results
GlobeNewswire
13 hours ago
Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024
MT Newswires
11 days ago
TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating
Zacks
11 days ago
Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid
Zacks
12 days ago
Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?
GlobeNewswire
17 days ago
Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
MT Newswires
24 days ago
Legend Biotech Says Myeloma Drug Shows Positive Overall Survival Results
GlobeNewswire
25 days ago
Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma
Compare LEGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LEGN Legend Biotech Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.